This company has been marked as potentially delisted and may not be actively trading. NASDAQ:INOV Inovalon (INOV) Stock Price, News & Analysis Add Compare Share Share Stock Analysis Stock AnalysisCompetitorsHeadlinesOwnershipSustainabilityTrendsBuy This Stock About Inovalon Stock (NASDAQ:INOV) 30 days 90 days 365 days Advanced Chart Remove Ads Get Inovalon alerts:Sign Up Key Stats Today's Range$30.13▼$30.1350-Day Range$40.66▼$41.0652-Week Range$17.56▼$41.06Volume17 shsAverage Volume720,587 shsMarket Capitalization$4.68 billionP/E Ratio88.63Dividend YieldN/APrice TargetN/AConsensus RatingN/A Company OverviewInovalon Holdings, Inc. engages in the development of cloud-based platforms for the healthcare industry. Its products include datasets, integration technologies, predictive analytics, and related services. The company was founded in 1998 and is headquartered in Bowie, MD.Read More… Remove Ads Inovalon Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks18th Percentile Overall ScoreINOV MarketRank™: Inovalon scored higher than 18% of companies evaluated by MarketBeat, and ranked 598th out of 662 stocks in the computer and technology sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's OpinionN/AAnalyst RatingN/A Consensus RatingThere is not enough analysis data for Inovalon. Earnings and Valuation1.3 / 5Proj. Earnings Growth11.67% Earnings GrowthEarnings for Inovalon are expected to grow by 11.67% in the coming year, from $0.60 to $0.67 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Inovalon is 88.63, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 22.55.Price to Earnings Ratio vs. SectorThe P/E ratio of Inovalon is 88.63, which means that it is trading at a more expensive P/E ratio than the Computer and Technology sector average P/E ratio of about 41.66.Price to Earnings Growth RatioInovalon has a PEG Ratio of 2.99. PEG Ratios above 1 indicate that a company could be overvalued.Price to Book Value per Share RatioInovalon has a P/B Ratio of 6.10. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities. Short InterestN/AShort Interest LevelN/A Short InterestThere is no current short interest data available for INOV. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldInovalon does not currently pay a dividend.Dividend GrowthInovalon does not have a long track record of dividend growth. Sustainability and ESG4.3 / 5Environmental Score-0.59 Short InterestThere is no current short interest data available for INOV. News and Social Media0.0 / 5News SentimentN/A News Coverage This WeekMarketBeat has tracked 1 news article for Inovalon this week, compared to 0 articles on an average week. Company Ownership1.7 / 5Insider TradingN/A Insider Buying vs. Insider SellingIn the past three months, Inovalon insiders have not sold or bought any company stock.Percentage Held by Insiders49.75% of the stock of Inovalon is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by InstitutionsOnly 33.15% of the stock of Inovalon is held by institutions.Read more about Inovalon's insider trading history. Receive INOV Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Inovalon and its competitors with MarketBeat's FREE daily newsletter. Email Address INOV Stock News HeadlinesInovalon Adds Safety Management to the PointClickCare MarketplaceApril 1 at 12:44 PM | tmcnet.comInovalon Enters Next Chapter of Innovation and Transformation Led by New CEO, Adam KanslerMarch 4, 2025 | finance.yahoo.comTrump… a socialist? Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to move your money now.April 1, 2025 | Porter & Company (Ad)Inovalon’s Patient Payment Solutions Are Now Available on the PointClickCare MarketplaceFebruary 27, 2025 | finance.yahoo.comInovalon's Patient Payment Solutions Are Now Available on the PointClickCare MarketplaceFebruary 27, 2025 | businesswire.comInovalon introduces AI-powered platform to expedite clinical trial recruitmentFebruary 26, 2025 | finance.yahoo.comInovalon Launches Clinical Research Patient Finder to Accelerate Trial RecruitmentFebruary 25, 2025 | finance.yahoo.comInovalon Launches Clinical Research Patient Finder to Accelerate Trial RecruitmentFebruary 25, 2025 | businesswire.comSee More Headlines INOV Stock Analysis - Frequently Asked Questions How were Inovalon's earnings last quarter? Inovalon Holdings, Inc. (NASDAQ:INOV) issued its quarterly earnings results on Wednesday, July, 28th. The technology company reported $0.19 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.17 by $0.02. The technology company had revenue of $190.44 million for the quarter, compared to analyst estimates of $183.89 million. Inovalon had a net margin of 6.73% and a trailing twelve-month return on equity of 10.97%. When did Inovalon IPO? Inovalon (INOV) raised $500 million in an initial public offering on Thursday, February 12th 2015. The company issued 22,200,000 shares at $21.00-$24.00 per share. Goldman Sachs, Morgan Stanley, Citigroup, BofA Merrill Lynch and UBS Investment Bank acted as the underwriters for the IPO and Baird, Piper Jaffray, Wells Fargo Securities and William Blair were co-managers. What other stocks do shareholders of Inovalon own? Based on aggregate information from My MarketBeat watchlists, some other companies that Inovalon investors own include NVIDIA (NVDA), Pfizer (PFE), Advanced Micro Devices (AMD), Moderna (MRNA), Meta Platforms (META) and PayPal (PYPL). Company Calendar Last Earnings7/28/2021Today4/01/2025Fiscal Year End12/31/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorComputer and Technology Industry Data Processing & Preparation Sub-IndustryN/A Current SymbolNASDAQ:INOV CIK1619954 Webwww.inovalon.com Phone(301) 809-4000Fax301-809-8060Employees1,836Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)$0.34 Trailing P/E Ratio88.63 Forward P/E Ratio50.22 P/E Growth2.99Net Income$22.58 million Net Margins6.73% Pretax Margin5.86% Return on Equity10.97% Return on Assets4.10% Debt Debt-to-Equity Ratio1.17 Current Ratio2.40 Quick Ratio2.40 Sales & Book Value Annual Sales$667.52 million Price / Sales7.01 Cash Flow$0.90 per share Price / Cash Flow33.35 Book Value$4.94 per share Price / Book6.10Miscellaneous Outstanding Shares155,246,000Free Float78,011,000Market Cap$4.68 billion OptionableNo Data Beta0.53 Social Links Beginner's Guide To Retirement StocksEnter your email address and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio. Get This Free Report This page (NASDAQ:INOV) was last updated on 4/1/2025 by MarketBeat.com Staff From Our PartnersA market crash is coming—here’s whenThe stock market cycle I've used to identify the most likely day of the next market crash is the exact same in...Chaikin Analytics | SponsoredTrump Allies Confirm Exec Order 14024 Triggers Dollar CollapseExecutive Order 14024 is paving the way for irreversible damage to the dollar's value—threatening your wealth,...Priority Gold | SponsoredElon Musk Confirms: Tesla’s Optimus is Replacing Workers… and Heading to MarsMusk confirmed that SpaceX's Starship will carry Optimus to Mars in 2026 as part of an autonomous mission to h...InvestorPlace | SponsoredRetirement Nightmare? It’s Already Happening.The market is on edge. Every day, another company slashes its dividend, leaving investors scrambling. Intel...Investors Alley | SponsoredNew “Trump” currency proposed in DCA former U.S. Presidential Advisor has come forward with a stern warning to investors: “Get out of tech, no...Paradigm Press | SponsoredNow I look stupid. Real stupid... I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredBrace Yourself for Jeff Bezos’ “Amazon Helios”Jeff Bezos quietly backing world-changing tech (not AI) The Amazon founder is quietly advancing a radical t...Stansberry Research | SponsoredThe Dirty Secret About Gold Mining Stocks...Here's something most gold analysts won't tell you: 90% of gold mining companies actually destroy sharehold...Golden Portfolio | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Inovalon Holdings, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Inovalon With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.